Biotech Holdings Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Holdings

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike Heimbuch who wrote (97)	1/31/1998 2:03:00 AM
From: jacq	Read Replies (1) of 224

Mike, It is good to hear from you again. As far as I know the scenario that BIO is putting forth - Afraid to partner up with a large pharmaceutical company because the company would make a close copy of the drug then run away with the profits.- does not make sense to me. What is to prevent a large pharmaceutical co. from obtaining a sample . I dentifying the contents, that must be fairly easy to do. Do a near duplication of the drug and beat BIO to the market? Doesen't it make more sense to sign iron bound confidentiality agreements which would at least give some paper trail of an intent to do business with BIO? Can you tell me a little more about how the company is presently acheiving revenue and whether they will in fact reach positive cash flow before they run out of cash?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next